New clinical support for ‘silent but deadly’ disease Chronic kidney disease detection and management resources have been released, days after it was labelled a ‘national emergency’.
Stronger myocarditis warnings after death linked to vaccine The stronger product information warning follows the death of a woman in her 20s, who died after receiving a Moderna booster.
How scrapped iso requirements impact telehealth The end of COVID isolation also means fewer exemptions to the 12-month telehealth rule.
PSA testing ‘dilemma’: A pathologist’s perspective Prostate cancer screening guidelines are typically debated by urologists and GPs, but a pathologist’s perspective adds extra nuance to a discussion often seen as black and white.
What do bivalent vaccines mean for Australia’s rollout? The first doses of Moderna’s variant-specific COVID vaccine became available this week, offering a slight advantage over previous versions.
‘A constellation of symptoms’: Long COVID in focus The first public hearing into long COVID has taken place as clinicians attempt to work out the scale of the problem, and one GP reports a rising demand for treatment.
Translating sleep disorder research into clinical settings A new GP education program will include an implementation network to improve access and use of sleep disorder resources in primary care.
Doubts over impact of key antiviral treatment A large UK study suggests molnupiravir has no effect on hospitalisations and deaths but reduces the overall recovery time from COVID-19.
How to make gambling harm part of ‘that general medical conversation’ The RACGP wants to support GPs to identify patients at risk of gambling harm in order to better implement targeted specialist treatment.
New Alzheimer’s medication found to slow cognitive decline The drug may be available as early as 2023, but there are still hurdles to cross, write Bernadette McGuinness and Elizabeth Coulthard.